Page last updated: 2024-08-25

rosiglitazone and Arterial Occlusive Diseases

rosiglitazone has been researched along with Arterial Occlusive Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bishop-Bailey, D; Hla, T; Warner, TD	1
Al-Omran, M; Cherng, WJ; Ciliberti, N; Fedak, PW; Li, RK; Li, SH; Stanford, WL; Szmitko, PE; Verma, S; Wang, CH; Weisel, RD	1

Other Studies

2 other study(ies) available for rosiglitazone and Arterial Occlusive Diseases

Article	Year
Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-gamma ligand therapy. Circulation research, 2002, Aug-09, Volume: 91, Issue:3 Topics: Animals; Arterial Occlusive Diseases; CD36 Antigens; Cell Line; Cells, Cultured; Cyclooxygenase 2; Drug Delivery Systems; Isoenzymes; Ligands; Male; Muscle, Smooth, Vascular; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Tunica Intima; Tunica Media	2002
Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Circulation, 2004, Mar-23, Volume: 109, Issue:11 Topics: Angioplasty; Animals; Arterial Occlusive Diseases; Bone Marrow Transplantation; Cell Differentiation; Cell Lineage; Cells, Cultured; Colony-Forming Units Assay; Culture Media, Conditioned; Endothelial Cells; Endothelium, Vascular; Femoral Artery; Humans; Hyperplasia; Male; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Multipotent Stem Cells; Muscle Cells; Muscle, Smooth, Vascular; Neovascularization, Physiologic; Radiation Chimera; Receptors, Cytoplasmic and Nuclear; Recombinant Proteins; Rosiglitazone; Thiazolidinediones; Transcription Factors; Tunica Intima; Vascular Endothelial Growth Factor A	2004

Article

Year

Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-gamma ligand therapy.

Circulation research, 2002, Aug-09, Volume: 91, Issue:3

Topics: Animals; Arterial Occlusive Diseases; CD36 Antigens; Cell Line; Cells, Cultured; Cyclooxygenase 2; Drug Delivery Systems; Isoenzymes; Ligands; Male; Muscle, Smooth, Vascular; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Tunica Intima; Tunica Media

2002

Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy.

Circulation, 2004, Mar-23, Volume: 109, Issue:11

Topics: Angioplasty; Animals; Arterial Occlusive Diseases; Bone Marrow Transplantation; Cell Differentiation; Cell Lineage; Cells, Cultured; Colony-Forming Units Assay; Culture Media, Conditioned; Endothelial Cells; Endothelium, Vascular; Femoral Artery; Humans; Hyperplasia; Male; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Multipotent Stem Cells; Muscle Cells; Muscle, Smooth, Vascular; Neovascularization, Physiologic; Radiation Chimera; Receptors, Cytoplasmic and Nuclear; Recombinant Proteins; Rosiglitazone; Thiazolidinediones; Transcription Factors; Tunica Intima; Vascular Endothelial Growth Factor A

2004